The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation-Reference-Cited by-同舟云学术

The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation

Published:2019-01 Issue:1 Volume:53 Page:1802089
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

van Leth Frank^ORCID,Brinkmann Folke,Cirillo Daniela M.,Dheda Keertan,Duarte Raquel,Guglielmetti Lorenzo^ORCID,Kuksa Liga,Lange Christoph,Mitnick Carole,Skrahina Alena,Zaman Khalequ,Bothamley Graham^ORCID

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference30 articles.

1. World Health Organization. Global Tuberculosis Report 2018. WHO/CDS/TB/2018.20 . Geneva, World Health Organization, 2018. Available from: www.who.int/tb/publications/global_report/en/

2. European Centre for Disease Prevention and Control, WHO Regional Office for Europe. Tuberculosis Surveillance and Monitoring in Europe 2018. 2016 data. Stockholm, European Centre for Disease Prevention and Control, 2018. Available from: https://ecdc.europa.eu/en/publications-data/tuberculosis-surveillance-and-monitoring-europe-2018

3. World Health Organization. The End TB Strategy . www.who.int/tb/strategy/end-tb/en/ Date last accessed: October 15, 2018.

4. ERS Clinical Research Collaborations: underpinning research excellence

5. Tbnet — Collaborative research on tuberculosis in Europe

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study;Journal of Infection;2022-06

2. Rifapentine access in Europe: growing concerns over key tuberculosis treatment component;European Respiratory Journal;2022-05

3. Cost and availability of drugs and treatment regimens and availability of drug resistance testing for tuberculosis in Europe;2022-02-15

4. Co-administration of treatment for rifampicin-resistant tuberculosis and chronic hepatitis C virus infection: a TBnet and ESGMYC study;2021-10-18

5. Use and impact of molecular methods for detecting drug‐resistant TB;The International Journal of Tuberculosis and Lung Disease;2021-02-01